Product Description & Mechanism of Action
Riomox CV 625 is a premier broad-spectrum antibiotic formulation combining Amoxicillin Trihydrate with Potassium Clavulanate. The addition of Clavulanic Acid inactivates beta-lactamase enzymes produced by resistant bacteria, thereby extending Amoxicillin’s spectrum of activity to include organisms normally resistant to beta-lactam antibiotics.